DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $852,000 | -63.1% | 42,226 | -31.8% | 0.00% | -100.0% |
| Q2 2021 | $2,312,000 | -29.2% | 61,910 | -51.5% | 0.00% | -50.0% |
| Q1 2021 | $3,264,000 | +463.7% | 127,617 | +386.1% | 0.00% | – |
| Q4 2020 | $579,000 | -5.1% | 26,255 | -22.6% | 0.00% | – |
| Q3 2020 | $610,000 | -38.4% | 33,920 | -12.9% | 0.00% | -100.0% |
| Q2 2020 | $990,000 | +166.1% | 38,951 | +92.3% | 0.00% | – |
| Q1 2020 | $372,000 | -81.2% | 20,253 | -77.5% | 0.00% | -100.0% |
| Q4 2019 | $1,983,000 | +354.8% | 89,995 | +195.5% | 0.00% | – |
| Q3 2019 | $436,000 | -51.6% | 30,451 | -46.7% | 0.00% | -100.0% |
| Q2 2019 | $900,000 | +35.5% | 57,117 | +26.2% | 0.00% | – |
| Q1 2019 | $664,000 | +33.1% | 45,272 | -3.1% | 0.00% | – |
| Q4 2018 | $499,000 | +91.2% | 46,712 | +173.2% | 0.00% | – |
| Q3 2018 | $261,000 | +536.6% | 17,097 | +412.3% | 0.00% | – |
| Q2 2018 | $41,000 | -89.7% | 3,337 | -92.0% | 0.00% | – |
| Q1 2018 | $398,000 | +105.2% | 41,590 | +93.6% | 0.00% | – |
| Q4 2017 | $194,000 | – | 21,478 | +27435.9% | 0.00% | – |
| Q3 2017 | $0 | – | 78 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 78 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 78 | -97.8% | 0.00% | – |
| Q4 2016 | $10,000 | +66.7% | 3,479 | +88.9% | 0.00% | – |
| Q2 2016 | $6,000 | -81.2% | 1,842 | -71.5% | 0.00% | – |
| Q1 2016 | $32,000 | -56.2% | 6,468 | -3.3% | 0.00% | – |
| Q4 2015 | $73,000 | +14.1% | 6,688 | -15.7% | 0.00% | – |
| Q3 2015 | $64,000 | -48.0% | 7,929 | -16.5% | 0.00% | – |
| Q2 2015 | $123,000 | +4000.0% | 9,493 | +8452.3% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 111 | -45.3% | 0.00% | – |
| Q4 2014 | $3,000 | +200.0% | 203 | +73.5% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 117 | +98.3% | 0.00% | – |
| Q2 2014 | $1,000 | -66.7% | 59 | -38.5% | 0.00% | – |
| Q1 2014 | $3,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |